Women's Treatment for Trauma and Substance Use Disorders - 1

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00078156
First received: February 19, 2004
Last updated: April 13, 2010
Last verified: April 2010
  Purpose

The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.


Condition Intervention Phase
Substance-Related Disorders
Behavioral: Behavior Therapy
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Women's Treatment for Trauma and Substance Use Disorders

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Drug abstinence

Estimated Enrollment: 409
Study Start Date: January 2004
Estimated Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria - Women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD.

Exclusion Criteria:

- Women will be excluded from the study who have current psychotic disorders, or a history of active psychosis (past two months); women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD; and women who have current psychotic disorders, or a history of active psychosis (past two months).

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00078156

Locations
United States, Florida
Gateway Community Services
Jacksonville, Florida, United States, 32224
The Villiage
Miami, Florida, United States, 33137
United States, New York
Addiction Research & Treatment Corp.-MSUCAS
Brooklyn, New York, United States, 11238
Addiction Research & Treatment Corp.-RISE
Brooklyn, New York, United States, 11238
United States, Ohio
Maryhaven, Inc.
Columbus, Ohio, United States, 43207
United States, South Carolina
Charleston Center
Charleston, South Carolina, United States, 29403
United States, Washington
Residence XII
Kirkland, Washington, United States, 98034
Sponsors and Collaborators
New York State Psychiatric Institute
Investigators
Principal Investigator: Denise Hien, Ph.D. New York State Psychiatric Institute
  More Information

No publications provided by National Institute on Drug Abuse (NIDA)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Denise Hien, Ph.D., New York State Psychiatric Institute
ClinicalTrials.gov Identifier: NCT00078156     History of Changes
Other Study ID Numbers: NIDA-CTN-0015-1
Study First Received: February 19, 2004
Last Updated: April 13, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 20, 2014